Inovio Pharmaceuticals Inc (NASDAQ: INO) shares fell 1.60%, or $ 0.14 per share, to close at $ 8.64 on Monday. After opening the day at $ 8.82, Inovio’s shares fluctuated between $ 9.08 and $ 8.63. 3,388,533 shares traded compared to the 30-day average of 5,922,724. Monday’s activity brought Inovio’s market cap to $ 1,817,483,581.
Inovio is headquartered in San Diego, California.
About Inovio Pharmaceuticals Inc
INOVIO is a biotechnology company focused on rapidly bringing to market precisely engineered DNA drugs to treat and protect people from infectious diseases, cancer, and HPV-related diseases. INOVIO is the first and only company to have clinically proven that a DNA drug can be delivered directly into the body’s cells via a proprietary intelligent device to generate a robust and tolerable immune response. INOVIO’s lead immunotherapy candidate, VGX-3100, currently in phase 3 trials for precancerous cervical dysplasia, has confirmed high-risk HPV-16 and / or HPV-18 in a phase 2b clinical trial. High-risk HPV is responsible for 70% of cervical cancer, 91% of anal cancer, and 69% of vulvar cancer. Programs targeting HPV-related cancers and a rare HPV-related disease, recurrent respiratory papillomatosis (RRP), are also under development; non-HPV-related cancers glioblastoma multiforme (GBM) and prostate cancer; and development programs for DNA vaccines against infectious diseases in coronaviruses associated with COVID-19 diseases and MERS, Lassa fever, Ebola and HIV. Partners and employees include Advaccine, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA) / Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) / Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute (IVI), Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Richter-Helm BioLogics, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. INOVIO is also the proud recipient of the “Women on Boards” 2020 award, which recognizes companies with more than 20% women on their board of directors.
Visit Inovio Pharmaceuticals Inc’s profile for more information.
Via the Nasdaq Stock Exchange
The Nasdaq Stock Market is a leading global provider of trading data and services, as well as the listing of stocks and options. Nasdaq is the world’s leading exchange for option volumes and is home to the five largest US companies – Apple, Microsoft, Amazon, Alphabet and Facebook.
For more information about Inovio Pharmaceuticals Inc. and to keep up with the latest company updates, please visit the company’s profile page here: Inovio Pharmaceuticals Inc. Profile For more financial market news, visit Equities News. Also, don’t forget to sign up for the Daily Fix to get the best stories in your inbox 5 days a week.
Sources: The chart is provided by TradingView based on 15 minute delayed prices. All other data will be made available by IEX Cloud starting at 8:05 p.m. ET on the day of publication.
The views and opinions expressed in this article are those of the authors and do not reflect the views of equities.com. Readers should not regard statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer
USA concludes withdrawal from Afghanistan and ends longest war
Robinhood drops 7% as PayPal investigates online brokerage and SEC verifies payment for order flow
California Wildfire Forces complete evacuation from South Lake Tahoe
Court of Appeal Ruling Bernie Madoff Trustee Can Prosecute Clawback Lawsuit Against Citigroup
China’s purchasing managers index falls to 50.1 in August
The takeover of Magnachip by a Chinese private equity firm poses a national security risk: US Treasury Department
Hurricane Ida is expected to cause much less economic damage than Katrina
Rivian Announces “Confidential” Filing Of Registration Statement For IPO